- Home
- MHI vs PROF Comparison
MHI vs PROF Comparison
Compare MHI & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHI
- PROF
- Stock Information
- Founded
- MHI 2003
- PROF N/A
- Country
- MHI United States
- PROF Canada
- Employees
- MHI N/A
- PROF N/A
- Industry
- MHI Investment Managers
- PROF Medical/Dental Instruments
- Sector
- MHI Finance
- PROF Health Care
- Exchange
- MHI Nasdaq
- PROF Nasdaq
- Market Cap
- MHI 214.3M
- PROF 238.5M
- IPO Year
- MHI N/A
- PROF N/A
- Fundamental
- Price
- MHI $9.68
- PROF $7.95
- Analyst Decision
- MHI
- PROF Strong Buy
- Analyst Count
- MHI 0
- PROF 2
- Target Price
- MHI N/A
- PROF $11.40
- AVG Volume (30 Days)
- MHI 98.8K
- PROF 40.9K
- Earning Date
- MHI 01-01-0001
- PROF 10-31-2024
- Dividend Yield
- MHI 4.09%
- PROF N/A
- EPS Growth
- MHI N/A
- PROF N/A
- EPS
- MHI 0.04
- PROF N/A
- Revenue
- MHI N/A
- PROF $7,880,000.00
- Revenue This Year
- MHI N/A
- PROF $56.87
- Revenue Next Year
- MHI N/A
- PROF $161.94
- P/E Ratio
- MHI $219.25
- PROF N/A
- Revenue Growth
- MHI N/A
- PROF 16.67
- 52 Week Low
- MHI $6.93
- PROF $7.11
- 52 Week High
- MHI $9.05
- PROF $11.69
- Technical
- Relative Strength Index (RSI)
- MHI 67.10
- PROF 36.56
- Support Level
- MHI $9.51
- PROF $7.50
- Resistance Level
- MHI $9.61
- PROF $8.32
- Average True Range (ATR)
- MHI 0.06
- PROF 0.40
- MACD
- MHI 0.01
- PROF -0.08
- Stochastic Oscillator
- MHI 95.18
- PROF 31.12
About MHI Pioneer Municipal High Income Fund Inc.
Pioneer Municipal High Income Trust is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income exempt from regular federal income tax and capital appreciation. The trust invests in various sectors such as health, education, tobacco, facilities, transportation, utilities, airport, water, and other sectors.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.